| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.002 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |